ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,324,000 | -27.4% | 17,701 | -38.9% | 0.31% | -22.1% |
| Q2 2020 | $1,824,000 | +22.7% | 28,971 | +14.3% | 0.40% | +10.7% |
| Q2 2019 | $1,487,000 | +106.5% | 25,356 | +53.6% | 0.36% | +219.3% |
| Q2 2018 | $720,000 | -58.7% | 16,509 | -62.6% | 0.11% | -60.7% |
| Q1 2018 | $1,742,000 | +16.1% | 44,112 | -0.1% | 0.29% | +7.8% |
| Q4 2017 | $1,501,000 | -37.7% | 44,176 | -53.2% | 0.27% | -15.9% |
| Q3 2017 | $2,408,000 | – | 94,435 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |